• Saturday,September 21,2024
gecos.fr
X

Has Rite Aid found the right prescription for growth? - RetailWire

$ 16.50

4.6 (637) In stock

Share

Rite Aid looks like it might be getting on a mini roll after years of struggling to compete in a retail drugstore market dominated by CVS and Walgreens.  Do you think Rite Aid has begun putting itself in a better position to be successful this year?

Rite Aid Opens First of 3 Small-Format Pharmacies in Underserved Communities - Retail TouchPoints

D&D Daily e-Newsletter

Rite Aid gets court approval for $575M Elixir sale to MedImpact

Rite Aid Touts PBM, Other Assets Amid Buyout Rumblings

Rite Aid Opioid Settlement: Victims Will Likely Get No Payout - Bloomberg

Rite Aid Loss Hits $306 Million As Troubles Mount

Gallelli Gazette_September 6th, 2023 by gallellire - Issuu

Rite Aid Wins Ruling Narrowing Claims in Generic Drug Price Case

Rite Aid's facial recognition software led store workers to falsely accuse shoppers of theft

Rite Aid's A.I. Facial Recognition Wrongly Tagged People of Color as Shoplifters - The New York Times

RetailWire on LinkedIn: #riteaid #pharmacy #bankruptcy #legalchallenges

Rite Aid - Wikipedia

Rite Aid plans to spend $700M over 2 years to change how its stores operate